课题基金 / 基金详情

COVID-19 Variant Supplement - Shutting down emerging Coronaviruses in humans now and in the future

COVID-19 Variant Supplement - Shutting down emerging Coronaviruses in humans now and in the future
COVID-19 变异补充剂 - 阻止现在和未来人类中新出现的冠状病毒
批准号:
443251
负责人:
Barr Stephen D
金额:
$3.64万
依托单位国家:
加拿大
项目类别:
Operating Grants
财政年份:
2021
资助国家:
加拿大
项目状态:
已结题
起止时间:
2021-02-01 至 2022-02-01

项目摘要

项目成果

Barr Stephen D的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
In December 2019, a pneumonia associated with the 2019 novel coronavirus SARS-CoV-2 emerged in Wuhan, China. This disease is now named COVID-19. Over 73,000 people have been infected worldwide and over 1,700 people have died from the disease. There is no
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Hiding the enemy within: gaining new insights into HIV integration and the establishment and maintenance of latency.
  • 批准号:
    493467
  • 项目类别:
    Operating Grants
  • 资助金额:
    $7.29万
  • 财政年份:
    2023
  • 负责人:
    Barr Stephen D
  • 依托单位:
Sex as a Biological Variable Supplement - Shutting down emerging Coronaviruses in humans now and in the future
  • 批准号:
    424687
  • 项目类别:
    Operating Grants
  • 资助金额:
    $3.64万
  • 财政年份:
    2020
  • 负责人:
    Barr Stephen D
  • 依托单位:
Shutting down emerging Coronaviruses in humans now and in the future
  • 批准号:
    422760
  • 项目类别:
    Operating Grants
  • 资助金额:
    $72.77万
  • 财政年份:
    2020
  • 负责人:
    Barr Stephen D
  • 依托单位:
Understanding how HIV integrase inhibitors, integrase inhibitor resistance mutants and non-B DNA reprogram integration site targeting for latency
  • 批准号:
    350802
  • 项目类别:
    Operating Grants
  • 资助金额:
    $18.16万
  • 财政年份:
    2016
  • 负责人:
    Barr Stephen D
  • 依托单位:
海外基金